2-methyl-5-nitro glyoxaline compound, preparation and use thereof

A technology of nitroimidazoles and nitroimidazoles, applied in the application field of nitroimidazole complexes and their precursors in tumor imaging agents, to achieve high tumor uptake

Inactive Publication Date: 2009-07-22
BEIJING NORMAL UNIVERSITY +1
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among the currently reported 99m Tc-labeled azamacrocyclic compounds mainly form 99m TCO ...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 2-methyl-5-nitro glyoxaline compound, preparation and use thereof
  • 2-methyl-5-nitro glyoxaline compound, preparation and use thereof
  • 2-methyl-5-nitro glyoxaline compound, preparation and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Compound MNIEC provided by the invention is synthesized according to the synthetic route shown below:

[0034]

[0035] The reagents used in each step are:

[0036] (a) EtOTFA, Et 3 N and MeOH;

[0037] (b) 2-bromoethanol, K 2 CO 3 and CH 3 CN;

[0038] (c)CH 3 SO 2 Cl, CH 2 Cl 2 and Et 3 N;

[0039] (d) Compound 1, K 2 CO 3 and CH 3 CN;

[0040] (e) NaOH and MeOH

[0041] Specific steps are as follows:

[0042] Synthesis of Tri-TFA cyclam (compound 1):

[0043] In a dry 50mL three-necked flask, cyclam (1.0g, 5mmol) and triethylamine (0.69mL, 5mmol) were dissolved in 20mL of anhydrous methanol, nitrogen protection was introduced and the reaction solution was kept at 0-5 with an ice-water bath. ℃, then added ethyl trifluoroacetate (6.0mL, 50.0mmol) dropwise, continued the dropwise addition for ten minutes, stirred and reacted for 7 hours, suspended and evaporated to remove the solvent, the residue was passed through a small silica gel column, and eth...

Embodiment 2

[0052] preparation 99m TcO-MNIEC complex

[0053] 1) 99m Preparation of TcO-GH

[0054] Weigh 25 mg of GH ligand, dissolve it completely with 0.5 mL of normal saline, add 0.5 mL of SnCl 2 2H 2 O (1mg / mL, 0.1M HCI), adjust pH=7-7.5, add 0.5mL of freshly rinsed 99m TCO 4 - The solution (approximately 10 mCi) was heated in a water bath at 40° C. for 10 minutes, then cooled to room temperature, and prepared as a precursor for the ligand exchange method.

[0055] 2) 99m Preparation of TcO-MNIEC

[0056] Dissolve 20 mg of the compound MNIEC ligand in 20 mL of methanol, take out 0.15 mL and put it into a penicillin vial, adjust the pH value to 13 with 1.0 mL of pH=13, that is, 0.1 M NaOH buffer solution, and add 0.15 mL of 99m Tc-GH solution, the mixture was heated in a boiling water bath for 45 minutes, and filtered through a filter membrane to obtain an electrically neutral and water-soluble target complex, and the labeling rate was greater than 95%.

Embodiment 3

[0058] preparation 99m TcN-MNIEC complex

[0059] (1) Intermediate [ 99m TcN] 2+ preparation of

[0060] Can be prepared in two ways 99m TcN intermediates, namely

[0061] Take 1~2mL 99m TCO 4 - Add the fresh eluent to the DTCZ kit, shake well, and heat in a boiling water bath for 15 minutes to obtain the intermediate [ 99m TcN] 2+ , the marking rate is greater than 98%;

[0062] or

[0063] Take 1~2mL 99m TCO 4 - Add the fresh eluent into the SDH kit, shake well, and let it stand at room temperature for 15 minutes to obtain the intermediate [ 99m TcN] 2+ , The labeling rate is above 98%.

[0064] (2) 99m Preparation of TcN-MNIEC

[0065] Take 0.1mL of the ligand solution MNIEC prepared above and put it into a penicillin vial, adjust the pH value of the MNIEC ligand solution to 13 with 1.0mL of 0.1M NaOH buffer solution, and then add 0.1mL[ 99m TcN] 2+ For the intermediate, heat in a boiling water bath for 40 minutes to obtain an electrically neutral and wate...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides hydrophilic complexes marked by radioactive nuclide for hypoxic tumors; and the precursor of the complexes is a 1, 4, 8, 11-tetraazacyclotetradecane-contained 2-methyl-5-nitromidazole compound with the structural formula as shown on the right. The invention also provides preparation methods of the complexes and the precursor thereof, and the application of the complexes as potential tumor hypoxia imaging agents; and the complexes have good hydrophilic property and relatively high uptake value in tumors, especially the complexes such as TcO-MNIEC and TcN-MNIEC have high absolute uptake value in tumors, low L/NT value, relatively high tumor/muscle ratio and tumor/blood ratio, effectively solve the problem that the current tumor hypoxia imaging agent has the defects of low absolute uptake value and high L/NT value, thus being likely to become new tumor hypoxia imaging agents with better performance.

Description

technical field [0001] The present invention relates to a class of radionuclide-labeled nitroimidazole complexes and their precursors for hypoxic tumors, and also relates to their preparation methods and their application in imaging agents for human or animal organs or tissues, especially The application in tumor imaging agent belongs to the fields of radiopharmaceuticals and nuclear medicine. Background technique [0002] Tissue hypoxia is a main feature of many clinically important diseases. Hypoxic cells are common in animal and human solid tumors, but hypoxic cells are not sensitive to radiotherapy and chemotherapy, so they often become an important cause of tumors that are difficult to cure and easy to relapse. reason. Detecting the oxygen level of the tumor before and after the treatment of tumor patients can evaluate the curative effect and help formulate the treatment plan. [0003] The use of non-invasive methods to determine tumor hypoxia has been widely valued. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D403/06C07F13/00A61K51/04A61K103/10
Inventor 王学斌王凤龙张现忠张俊波陆洁唐志刚刘键
Owner BEIJING NORMAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap